Nocturnal hormones and clinical rhythms in rheumatoid arthritis

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 372-381

  Cutolo, Maurizio ^a,c   Otsa, Kati ^b   Aakre, Oivi ^b   Sulli, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Central Hospital   (Estonia)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Circadian rhythms; Cortisol; Cytokines; Europe; Melatonin; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; CYTOKINE; HYDROCORTISONE; MELATONIN;

CIRCADIAN RHYTHM; CONFERENCE PAPER; CORTICOSTEROID METABOLISM; CORTICOSTEROID RELEASE; CYTOKINE PRODUCTION; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LIGHT EXPOSURE; MORNING STIFFNESS; NIGHT; PINEAL BODY; RHEUMATOID ARTHRITIS; RISK FACTOR; SYMPTOM; SYMPTOMATOLOGY; TH1 CELL; TH2 CELL;

EID: 25444527943     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.079     Document Type: Conference Paper

References (51)

1. CUTOLO, M. & A.T. MASI. 2005. Circadian rhythms and arthritis. Rheum. Dis. Clin. North. Am. 31: 115-129.
2. LABRECQUE, G., J.P. BUREAU & A.E. REINBERG. 1995. Biological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs. Pharmac. Ther. 66: 285-300.
3. HARKNESS, J.A., M.B. RICHTER, G.S. PANAYI, et al. 1982. Circadian variation in disease activity in rheumatoid arthritis. Br. Med. J. 284: 551-554.
4. LATMAN, N.S. 1983. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am. J. Med. 74: 957-960.
5. MUIR, V.Y. & R. POWNALL. 1983. Identification of a seven day biological cycle in the rat. J. Pharm. Pharmac. 35: 186-188.
6. LOUBARIS, N., G. CROS, J.J. SERRANO & M. BOUCARD. 1983. Circadian and circannual variation of the carrageenan inflammatory effect in the rat. Life Sci. 32: 1349-1354.
7. LABREQUE, G., F. DORE & P.M. BERLANGER. 1981. Circadian variation of carrageenanpaw edema in the rat. Life Sci. 28: 1337-1343.
8. MAESTRONI, G.J., A. CONTI & W. PIERPAOLI. 1986. Role of the pineal gland in immunity: circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J. Neuroimmunol. 13: 19-30.
9. REITER, R.J. 1991. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12: 151-180.
10. MAESTRONI, G.J. 1993. The immunoneuroendocrine role of melatonin. J. Pineal Res. 14: 1-10.
11. MAESTRONI, G.J. 1995. T-helper-2 lymphocytes as a peripheral target of melatonin. J. Pineal Res. 18: 84-89.
12. BARRIGA, C., M.I. MARTIN, E. ORTEGA & A.B. RODRIGUEZ. 2002. Physiological concentrations of melatonin and corticosterone in stress and their relationship with phagocytic activity. J. Neuroendocrinol. 14: 691-695.
13. ESQUIFINO, A.I. & D.P. CARDINALI. 1999. Effects of melatonin on 24-h rhythms of neuroendocrine and immune changes in Freund's adjuvant-induced arthritis. Neuro. Endocrinol. Lett. 20: 163-166.
14. GARCIA-MAURINO, S., M.G. GONZALEZ-HABA, J.R. CALVO, et al. 1997. Melatonin enhances IL-2, IL-6 and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 159: 574-581.
15. CARDINALI, D.P., A.P. GARCIA, P. CANO & A.I. ESQUIFINO. 2004. Melatonin role in experimental arthritis. Curr. Drug Targets Immune Endocr. Metabol. Disord. 4: 1-10.
16. CUTOLO, M., G.J. MAESTRONI, K. OTSA, et al. 2005. Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann. Rheum. Dis. 64: 212-216.
17. CUTOLO, M., B. VILLAGGIO, F. CANDIDO, et al. 1999. Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann. N.Y. Acad. Sci. 876: 246-254.
18. SCHEER, F.A. & R.M. Buus. 1999. Light affects morning salivary cortisol in humans. J. Clin. Endocrinol. 84: 3395-3398.
19. PETROVSKY, N., P. MCNAIR & L. HARRISON. 1998. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 10: 307-312.
20. MIYATAKE, A., Y. MORIMOTO, T. OISHI, et al. 1980. Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin, and cortisol in normal men. J. Clin. Endocrinol. Metab. 51: 1365-1371.
21. GUDEWILL, S., I. POLLMACHER, H. VEDDER, et al. 1992. Nocturnal plasma levels of cytokines in healthy men. Eur. Arch. Psychiatry Clin. Neurosci. 242: 53-56.
22. MORREY, K.M., J.A MCLACHLAN, C.D. SERKIN & O. BAKOUCHE. 1994. Activation of human monocytes by the pineal hormone melatonin. J. Immunol. 153: 2671-2680.
23. LISSONI, P., F. ROVELLI, F. BRIVIO, et al. 1998. Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to light/dark rhythm of the pineal hormone melatonin in healthy humans. Nat. Immun. 16: 1-5.
24. LISSONI, P. 2000. Modulation of anticancer cytokines IL-2 and IL-12 by melatonin and the other pineal indoles 5-methoxytryptamine and 5-methoxytrypholol in the treatment of human neoplasms. Ann. N.Y. Acad. Sci. 917: 560-567.
25. MAESTRONI, G.J., D.P. CARDINALI, A.I. ESQUIFINO, et al. 2005. Does melatonin play a disease-promoting role in rheumatoid arthritis? J. Neuroimmunol. 158: 106-111.
26. LIU, F., T.B. NG & M.C. FUNG. 2001. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J. Neural Transm. 108: 397-405.
27. PETROVSKY, N. & L.C. HARRISON. 1998. The chronobiology of human cytokine production. Int. Rev. Immunol. 16: 635-649.
28. PETROVSKY, N. 2001. Towards a unified model of neuroendocrine-immune interaction. Immunol. Cell Biol. 79: 350-357.
29. MASI, A.T., S.L. FEIGENBAUM, R.T. CHATTERTON & M. CUTOLO. 1995. Integrated hormonal-immunological-vascular (H-I-V triad) systems interactions in the rheumatic diseases. Clin. Exp. Rheumatol. 13: 203-216.
30. CHROUSOS, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1362.
31. GUDBJORNSSON, B., B. SKOGSEID, B. OBERG, et al. 1996. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J. Rheumatol. 23: 596-602.
32. WEST, H.F. 1996. Corticosteroid metabolism and rheumatoid arthritis. Ann. Rheum. Dis. 16: 173-181.
33. MASI, A.T. & G.P. CHROUSOS. 1996. Hypothalamic-pituitary-adrenal- glucocorticoid axis function in rheumatoid arthritis. J. Rheumatol. 23: 577-581.
34. STRAUB, R.H. & M. CUTOLO. 2001. Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: view-point based on a systemic pathogenetic role. Arthritis Rheum. 44: 493-507.
35. CROFFORD, L.J., K.T. KALOGERAS, G. MASTORAKOS, et al. 1997. Circadian relationships between interleukin IL-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82: 1279-1283.
36. CUTOLO, M., L. FOPPIANI, C. PRETE, et al. 1999. Hypothalamic-pituitary- adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J. Rheumatol. 26: 282-288.
37. ARVIDSON, N.G., G. GUDBJORNSSON, L. ELFMAN, et al. 1994. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann. Rheum. Dis. 53: 521-524.
38. TEMPL, E., M. KOELLER, M. RIEDL, et al. 1996. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br. J. Rheumatol. 35: 350-356.
39. MASTORAKOS, G., G.P. CHROUSOS & J.S. WEBER. 1993. Recombinant interleukin-6 activates the hypothalamic pituitary-adrenal axis in human. J. Clin. Endocrinol. Metab. 77: 1690-1694.
40. EHRHART-BORNSTEIN, M., J.P. HINSON, S.R. BORNSTEIN, et al. 1998. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 19: 101-104.
41. DEKKERS, J.C., R. GEENEN, G.L. GODAERT, et al. 2000. Diurnal rhythm of salivary cortisol levels in patients with recent onset rheumatoid arthritis. Arthritis Rheum. 43: 465-467.
42. STRAUB, R.H., L. PAIMELA, R. PELTOMAA, et al. 2002. Inadequately low serum levels of steroid hormones in relation to IL-6 and TNF in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum. 46: 654-662.
43. VAN EVERDINGEN, A.A., J.W. JACOBS, D.R. SIEWERTSZ VAN REESEMA & J.W. BIJLSMA. 2002. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann. Intern. Med. 136: 1-12.
44. SULLI, A., G.J. MAESTRONI, B. VILLAGGIO, et al. 2002. Melatonin serum levels in rheumatoid arthritis. Ann. N.Y. Acad. Sci. 966: 276-283.
45. SCHULZE-KOOPS, H., P.E. LIPSKY, A.F. KAVANAUGH & L.S. DAVIS. 1995. Elevated Th1 or Th2-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. J. Immunol. 155: 5029-5037.
46. MAESTRONI, G.J., A. SULLI, C. PIZZORNI, et al. 2002. Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann. N.Y. Acad. Sci. 966: 271-275.
47. MAESTRONI, G.J., A. SULLI, C. PIZZORNI, et al. 2002. Melatonin in rheumatoid arthritis: a disease promoting and modulating hormone? Clin. Exp. Rheumatol. 20: 872-873.
48. CANTORNA, M.T. 2000. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 223: 230-233.
49. ROZIN, A., A. BALBIR-GURMAN & D. SHAPIRA. 2003. Seasonal distribution of relapse onset in rheumatoid arthritis and spondyloarthropathy: the possible effect of solar factor. Clin. Exp. Rheumatol. 21: 161-169.
50. CUTOLO, M. 2003. Solar light effects on onset/releases and circannual/circadian symptomatology in rheumatoid arthritis. Clin. Exp. Rheum. 21: 148-150.
51. OTSA, K., T. PEETS, G. MAESTRONI, et al. 2004. Circadian rhythms of melatonin in Estonian rheumatoid arthritis patients. Ann. Rheum. Dis. 63: S139.